BioSpace News Archive

Biotech Bay

National Comprehensive Cancer Network® Adds Newly Approved REZLIDHIA™ (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that REZLIDHIA™ (olutasidenib) has been added by the National Comprehensive Cancer Network® (NCCN®) to the latest NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for acute myeloid leukemia (AML).

January 18, 2023
·
10 min read
Drug Development

Trefoil Therapeutics Announces First Patient Dosed in Phase 1 Study of TTHX1114 for Treatment of Corneal Epithelial Defects

Trefoil Therapeutics today announced the dosing of the first patient in its Phase 1 safety study evaluating TTHX1114.

January 18, 2023
·
4 min read
Business

Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors

Structure Therapeutics Inc. today announced the appointments of Eric Dobmeier and Joanne Waldstreicher, M.D., to its Board of Directors.

January 18, 2023
·
3 min read
Drug Development

ORYZON Announces First Patient In in NET, a Collaborative Phase II Basket Study With Iadademstat in R/R Patients With Neuroendocrine Carcinomas

Oryzon Genomics, S.A. announced today the enrollment of the first patient in a Phase II collaborative study with iadademstat in patients with relapsed/refractory high grade neuroendocrine carcinomas (NEC).

January 18, 2023
·
8 min read
Genetown

Pear Therapeutics Announces Inclusion of reSET® and reSET-O® on the January 2023 Florida Medicaid Preferred Drug List

Pear Therapeutics Announces Inclusion of reSET ® and reSET-O ® on the January 2023 Florida Medicaid Preferred Drug List.

January 18, 2023
·
11 min read
Drug Development

Horizon Therapeutics plc Announces Phase 2 Trial Evaluating Dazodalibep for the Treatment of Sjögren’s Syndrome Meets Primary Endpoint in the Second Study Population

Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the primary endpoint was met for the second population in its Phase 2 clinical trial evaluating dazodalibep for the treatment of Sjögren’s syndrome.

January 18, 2023
·
7 min read
Business

enVVeno Medical Promotes Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer

enVVeno Medical Corporation today announced the promotion of Dr. Hamed Alavi to Senior Vice President and Chief Technology Officer.

January 18, 2023
·
5 min read
Biotech Beach

Evoke Pharma Announces Acceptance of an Abstract at the Academy of Managed Care Pharmacy (AMCP) Annual Meeting 2023

Evoke Pharma, Inc. today announced that its abstract entitled “Real-World Healthcare Resource Utilization of Patients Treated with Metoclopramide Nasal for Diabetic Gastroparesis (DGP)” will be presented at the Academy of Managed Care Pharmacy (AMCP) annual meeting.

January 18, 2023
·
8 min read
Pharm Country

Boekel Scientific Introduces Large Paraffin Wax Dispenser

Boekel Scientific introduces two new items to help enhance histology and anatomical pathology laboratories: a new Large Wax Dispenser and a Microscope Slide Storage Cabinet Wheeled Base Dolly.

January 18, 2023
·
2 min read
Arkstone’s OneChoice Treatment Recomendations Now Include Renal and Hepatic Reference Adjustments

Arkstone Medical Solutions, the leading provider of laboratory infectious disease reporting and proactive antimicrobial stewardship, has once again raised the bar in infectious disease analysis for laboratory results, by enhancing the already groundbreaking OneChoice targeted treatment recommendations with the addition of dynamic renal and hepatic dosing adjustments.

January 18, 2023
·
3 min read